Evidence map›Paper›PMID 41114797›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

AT1 receptors mediate the effects of cold stress and amphetamine on neurocognitive performance.

Natalia Andrea Marchese, Victoria Belén Occhieppo, Sol Micaela Angulo, Mariela Fernanda Pérez, Claudia Bregonzio

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia Andrea Marchese *Instituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología "Otto Orsingher", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.ORCID http://orcid.org/0000-0003-3636-9910
Victoria Belén Occhieppo *Instituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología "Otto Orsingher", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.ORCID http://orcid.org/0000-0002-9325-3458
Sol Micaela AnguloInstituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología "Otto Orsingher", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Mariela Fernanda PérezInstituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología "Otto Orsingher", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.ORCID http://orcid.org/0000-0002-7337-9248
Claudia BregonzioInstituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología "Otto Orsingher", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina. claubregonzio@unc.edu.ar.ORCID http://orcid.org/0000-0003-3542-2177

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas PIP 2022Fondo para la Investigación Científica y Tecnológica BID PICT 2016 Nº403
6 · The paper itself

Abstract

Brain angiotensin II (Ang II) modulates catecholamine neurotransmission via its AT1 receptors (AT1-R) and plays a critical role in neurocognitive processes. We previously showed that amphetamine (Amph) exposure induced cognitive alterations, many times unmasked by further Amph or Ang II challenge administration. In this work, we aimed to evaluate whether Amph exposure modifies the future neurocognitive response to cold stress, an environmental cue, and the possible role of the AT1-R. Male Wistar rats received AT1-R blocker (Candesartan)/Vehicle from day 0 to 5, and Amph/Saline from day 6 to 10. After 7 days of withdrawal, the animals were exposed to a cold stress challenge (4 °C for 4 h) and tested for working and long-term memory. Cold stress reversed the Amph-induced working memory deficit, while previous Amph exposure blunted the interference of cold stress on long-term memory consolidation. Blood adrenaline and glucose levels were increased in the Amph-treated animals after cold stress and/or test exposure. Remarkably, the AT1-R blockade prevented all the alterations induced by Amph exposure and elicited by cold-challenge. Our results indicate that Amph-induced neuroadaptations exhibit a wide range of responses to a catecholamine-releasing stimuli, including pharmacological or non-pharmacological challenges, such as environmental conditions, involving the AT1-R.

Indexed as

AmphetamineCognitionCold-Shock ResponseReceptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersAnimalsBlood GlucoseCold TemperatureEpinephrineMaleMemory, Long-TermMemory, Short-TermRatsRats, WistarAmphetamineAngiotensin II Type 1 Receptor BlockersBlood GlucoseEpinephrineReceptor, Angiotensin, Type 1AmphetamineAngiotensin IIAT1-receptorCold stressWorking memory

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.